Therapeutic development for muscular dystrophy

Strykagen is a biopharmaceutical company devoted to the development of therapeutics and diagnostics for life-threatening rare muscle diseases. Our portfolio of biologics and small molecules stabilize the myomatrix, and target disease modifiers which have been shown to prevent muscle disease progression. By designing and implementing risk adjusted business strategies, we have achieved over $3M in funding (SBIR/STTR grants and private investment from a major biotechnology company), implemented private partnerships for therapeutic commercialization, and developed framework for IND applications, FDA regulations and orphan drug designations. • Established all compliances and operational practices for company launch. • Discovered and implemented research collaboration and partnerships with top tier pharmaceutical companies and venture capital investors. • Simplified commercialization strategy development for broad portfolio of Intellectual Property (10 broad patents covering biologic and small molecule therapeutics). • Organized project road maps and commercialization strategies for 5 SBIR/STTR funded proposals and all associated compliances related to successful government contracting.• Established relations with multiple industry leaders to implement research alliances and partnerships• Conducted business development practices to include fundraising, private partnerships, licensing agreements, option agreements, term sheet negotiations, intellectual property/patents, allocation of rights agreements, MTA’s, CDA’s, and subcontracts.

RABD is my personal business consulting firm specializing in professional economist support, data analytics, market forecasting, financial modeling, and fundraising for multistage growth opportunities. RABD uses a proprietary method to forecast your business needs and growth trajectory based on client expectations and needs.• Current client support assisted a $10.5M raise for a university start up in the type 2 diabetes therapeutics development sector. • Conducted fiscal management, SBIR/STTR proposal, and business development strategies for multiple university based start-up companies.

M2 Medical Intelligence is a leading intelligence-driven healthcare solutions company devoted to providing intuitive analytic solutions at the “point of need” hospital setting. • Introduced fiscal strategies to reduce company debt and gain market traction with local government contracts• Client management and economist support to simplify data analytic outputs for use by the state of Nevada’s COVID response teams (Nevada Hospital Association).• Managed full project commercialization strategy for investor interest and associated metrics. • Conducted cost-benefit analysis of new product launches to minimize risk and maximize market traction.• Applied internal software development cycles for agile client based software development strategies.

DxDiscovery is a diagnostics company focused on creating rapid, point-of-care immunoassays for infectious diseases. By designing and implementing risk adjusted business strategies, I have been able to employ 20 students directly out of the university talent pool, achieved over $8.5M in SBIR/STTR grants, and generated IP and licensing opportunities for the portfolio of prototype diagnostic tests. Highlights of my time as a founding member of the company include.• Conducted cost-benefit analysis for business formation and launch focused on technology translation, value proposition refinement, pitch deck optimization, and full scale operational practices (finance, accounting, reporting, management, and HR). • Introduced commercialization strategies for a broad scale of opportunities including infectious disease rapid diagnostics (Melioidosis, Pertussis, Lyme disease, Mucormycosis), Fungal disease rapid diagnostics (Dermatophyte skin, hair and nail infections), veterinary fungal disease rapid diagnostics (Dermatophyte skin and hair infections), and agricultural diagnostics (Citrus Greening (HLB))• Organized project road maps and commercialization strategies for 14 SBIR/STTR funded proposals and all associated compliances related to successful government contracting.• Successful legal relations including fundraising, private partnerships, licensing agreements, option agreements, intellectual property/patents, allocation of rights agreements, MTA’s, CDA’s, and subcontracts.

Ethics and Professionalism in Biotechnology

Economics, Entrepreneurship

Investigation on the feasibility for proposed patents with an emphasis in local economic development. Coordinate the efforts of current research being performed at the University of Nevada, Reno and involve industry at an earlier stage. This includes extensive research of industry needs within the market for several different technologies being developed at the University. Develop economic models to justify costs and benefits of technology for market preparation.

Provide guests with the best service in Northern Nevada.